PROCEPT BioRobotics Corporation (PRCT) Ownership
PRCT ownership summary
as of October 18, 2026- Institutions
- 97.8% of shares outstanding
- Insiders
- 3.49% of shares outstanding
- Shares outstanding
- 56.9M
- Float
- 55.8M shares available to trade
- Short interest
- 13.35% 7.4M shares short
- Days to cover
- 5.41 short interest down 0.2% vs prior month
- Institutions 97.75%
- Insiders 3.49%
PRCT top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 8.50% | 4.9M | $85.6M | +507,826 (+11.6%) | June 30, 2026 |
| 2 | T. Rowe Price Investment Management,Inc. | 5.70% | 3.3M | $57.4M | −8,090 (−0.2%) | June 30, 2026 |
| 3 | BNP Paribas Investment Partners SA | 4.93% | 2.8M | $49.6M | −265,529 (−8.6%) | June 30, 2026 |
| 4 | Vanguard Portfolio Management, LLC | 4.41% | 2.5M | $44.4M | +105,440 (+4.4%) | June 30, 2026 |
| 5 | Vanguard Capital Management, LLC | 4.30% | 2.5M | $43.2M | +61,735 (+2.6%) | June 30, 2026 |
| 6 | Chicago Capital LLC | 3.62% | 2.1M | $36.4M | −87,350 (−4.0%) | June 30, 2026 |
| 7 | State Street Corp | 2.82% | 1.6M | $28.4M | +87,844 (+5.7%) | June 30, 2026 |
| 8 | Geode Capital Management, LLC | 2.59% | 1.5M | $26.1M | +120,663 (+8.8%) | June 30, 2026 |
| 9 | FMR Inc | 2.52% | 1.4M | $25.4M | −17,026 (−1.2%) | June 30, 2026 |
| 10 | T. Rowe Price Associates, Inc. | 2.33% | 1.3M | $23.4M | +726,494 (+119.9%) | June 30, 2026 |
| 11 | Wellington Management Company LLP | 2.22% | 1.3M | $22.4M | +412,399 (+47.9%) | June 30, 2026 |
| 12 | Federated Hermes Inc | 2.19% | 1.3M | $22.0M | +1.1M (+618.6%) | June 30, 2026 |
| 13 | Jupiter Topco LLC | 1.93% | 1.1M | $19.4M | +1.1M (0.0%) | June 30, 2026 |
| 14 | Frontier Capital Management CO Inc | 1.91% | 1.1M | $19.2M | +481,671 (+79.0%) | June 30, 2026 |
| 15 | Soleus Capital Management, L.P. | 1.75% | 1.0M | $17.6M | +843,000 (+526.9%) | June 30, 2026 |
| 16 | Champlain Investment Partners, LLC | 1.71% | 981K | $17.2M | −154,941 (−13.6%) | June 30, 2026 |
| 17 | Baillie Gifford & Co Limited. | 1.59% | 912K | $16.0M | −61,751 (−6.3%) | June 30, 2026 |
| 18 | Fiera Capital Corporation | 1.35% | 775K | $13.6M | −193,026 (−19.9%) | June 30, 2026 |
| 19 | LMR Partners LLP | 1.26% | 722K | $12.7M | +721,608 (0.0%) | June 30, 2026 |
| 20 | William Blair Investment Management, LLC | 1.24% | 709K | $12.5M | +285,175 (+67.2%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 13 holders added 6.5M shares and 7 cut 788K.
PRCT top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 2.98% | 1.7M | $30.0M | — | August 31, 2026 |
| 2 | iShares Russell 2000 ETF | 2.53% | 1.4M | $25.4M | −16,704 (−1.1%) | September 30, 2026 |
| 3 | T. Rowe Price Small-Cap Stock | 2.28% | 1.3M | $23.0M | −7,526 (−0.6%) | September 30, 2026 |
| 4 | Vanguard Small Cap Index | 2.14% | 1.2M | $21.5M | −17,593 (−1.4%) | September 30, 2026 |
| 5 | Janus Henderson Venture D | 1.87% | 1.1M | $18.8M | +181,718 (+20.4%) | August 31, 2026 |
| 6 | T. Rowe Price Instl Small-Cap Stock | 1.22% | 696K | $12.2M | — | September 30, 2026 |
| 7 | BNP Paribas Health Cr Innovtr Cl Cap | 1.21% | 691K | $12.1M | −126 (−0.0%) | August 31, 2026 |
| 8 | Vanguard MStar Small Cap Growth Indx Inv | 1.19% | 682K | $12.0M | −30,402 (−4.3%) | September 30, 2026 |
| 9 | Rhenman Healthcare Equity L/S RC2 SEK | 1.16% | 666K | $11.7M | +55,000 (+9.0%) | January 31, 2026 |
| 10 | BNP Paribas US Small Cap ClassicC | 1.12% | 643K | $11.3M | −1,232 (−0.2%) | August 31, 2026 |
| 11 | T. Rowe Price New Horizons | 1.07% | 615K | $10.8M | — | September 30, 2026 |
| 12 | Fidelity Small Cap Index | 1.07% | 614K | $10.8M | +4,119 (+0.7%) | July 31, 2026 |
| 13 | Federated Hermes MDT Small Cap Core IS | 1.06% | 608K | $10.7M | +544,469 (+855.3%) | June 30, 2026 |
| 14 | iShares Russell 2000 Growth ETF | 0.93% | 530K | $9.3M | −671 (−0.1%) | September 30, 2026 |
| 15 | Global X Robotics & Artfcl Intllgnc ETF | 0.84% | 481K | $8.4M | — | September 30, 2026 |
| 16 | Mirova Thematic AI & Robotics I/A USD | 0.83% | 477K | $8.4M | +2,129 (+0.4%) | December 31, 2025 |
| 17 | Champlain Small Company Adv | 0.70% | 401K | $7.0M | −116,000 (−22.4%) | June 30, 2026 |
| 18 | AXAWF Robotech G Cap USD | 0.69% | 396K | $7.0M | −7,386 (−1.8%) | August 31, 2026 |
| 19 | C WorldWide Healthcare Select 1A | 0.65% | 375K | $6.6M | — | June 30, 2026 |
| 20 | Vanguard Russell 2000 ETF | 0.57% | 326K | $5.7M | +3,302 (+1.0%) | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
PRCT insider transactions
latest 13| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-19 | Alaleh Nouri | Sell | $25.96 | 5,363 | $139,223 |
| 2026-03-17 | Alaleh Nouri | Sell | $28.15 | 304 | $8,558 |
| 2026-03-17 | Kevin Waters | Sell | $28.15 | 706 | $19,874 |
| 2026-03-10 | Alaleh Nouri | Sell | $25.65 | 3,243 | $83,183 |
| 2026-03-09 | Antal Rohit Desai | Buy | $24.55 | 98,699 | $2.4M |
| 2026-03-06 | Alaleh Nouri | Sell | $23.70 | 6,892 | $163,340 |
| 2026-03-06 | Antal Rohit Desai | Buy | $23.59 | 160,317 | $3.8M |
| 2026-03-06 | Kevin Waters | Sell | $23.70 | 6,721 | $159,288 |
| 2026-03-05 | Antal Rohit Desai | Buy | $25.58 | 167,246 | $4.3M |
| 2025-06-12 | Antal Rohit Desai | Sell | $61.49 | 25,000 | $1.5M |
| 2025-06-10 | Antal Rohit Desai | Sell | $63.91 | 25,000 | $1.6M |
| 2025-06-05 | Antal Rohit Desai | Sell | $64.79 | 25,000 | $1.6M |
| 2025-06-03 | Antal Rohit Desai | Sell | $60.66 | 25,000 | $1.5M |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
PRCT shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns PRCT
Institutional investors own 97.8% of PROCEPT BioRobotics's shares and insiders 3.49%. The largest holder is BlackRock Inc with 8.50% of the shares (4.9M), as of June 30, 2026. Among the top 20 institutions, 13 added shares and 7 reduced their stake in the latest filings. Short interest is 13.35% of the float, or 5.41 days of average trading volume. The share count rose 59.6% since 2020.
Related: PRCT analyst forecast, PRCT key metrics. See the PRCT stock overview for the latest quote and news.
PRCT ownership FAQ
Who owns the most PROCEPT BioRobotics stock?
The largest shareholders of PROCEPT BioRobotics are BlackRock Inc (8.50%), T. Rowe Price Investment Management,Inc. (5.70%), BNP Paribas Investment Partners SA (4.93%), Vanguard Portfolio Management, LLC (4.41%), Vanguard Capital Management, LLC (4.30%).
What percentage of PROCEPT BioRobotics is owned by institutions?
Institutions hold 97.8% of PROCEPT BioRobotics's shares outstanding; insiders hold 3.49%.
Which funds own PROCEPT BioRobotics?
The largest fund holders of PROCEPT BioRobotics are Vanguard MStar Total Stk Mkt Idx Invest (2.98%), iShares Russell 2000 ETF (2.53%), T. Rowe Price Small-Cap Stock (2.28%), Vanguard Small Cap Index (2.14%), Janus Henderson Venture D (1.87%).
What is PROCEPT BioRobotics's short interest?
7.4M shares of PROCEPT BioRobotics were sold short, 13.35% of the float; at the average daily volume it would take 5.41 days to cover.
Are insiders buying or selling PROCEPT BioRobotics?
Of the latest 13 reported insider transactions in PROCEPT BioRobotics (since June 3, 2025), 3 were purchases and 10 were sales.
How many shares of PROCEPT BioRobotics are outstanding?
PROCEPT BioRobotics has 56.9M shares outstanding, of which 55.8M are in the public float.